of noradrenergic, serotonergic, cholinergic and opioidergic mechanisms in PCA-induced central analgesia in mice. The mice administered 300 mg/kg PCA (p.o.) were pre-treated with α 2 -adrenoceptor antagonist yohimbine (1 mg/kg, i.p.), serotonin 5-HT 2A/2C receptor antagonist ketanserin (1 mg/kg, i.p.), non-specific muscarinic antagonist atropine (5 mg/kg, i.p.) and non-specific opioid antagonist naloxone (5 mg/kg, i.p.), respectively. The analgesia test procedures were performed 45 minutes after PCA administration. The hot-plate (integrated supraspinal response) and tail-immersion (spinal reflex) tests were used and pain thresholds which are indicated by the withdrawal response latency to the thermal stimuli 4 were evaluated. The enhancement in the latency of PCA-induced response to thermal stimuli was reversed by yohimbine and naloxone pretreatments in hot-plate test, while it was reversed by yohimbine, naloxone and also atropine in tail-immersion test.
Abstract
Ferulic acid is a caffeic acid derivative and a common phenolic compound quite abundant in various medicinal plants that used for pain relief. The antinociceptive effect of ferulic acid has been shown; however, the action mechanisms of ferulic acid still remain unclear. The purpose of the present study was to investigate the possible mechanism of action of ferulic acid-induced antinociception in vivo by using hot-plate and tail-immersion tests. The involvement of noradrenergic, serotonergic, opioidergic and cholinergic mechanisms on the antinociception induced by 80 mg/kg ferulic acid were investigated by examining the effects of 1 mg/kg yohimbine as an α 2 -adrenoceptor antagonist, 1 mg/kg ketanserin as a serotonin 5-HT 2A/2C receptor antagonist, 5 mg/kg naloxone as a non-specific opioid antagonist, 5 mg/kg atropine as a nonspecific muscarinic antagonist and 1 mg/kg mecamylamine as a non-specific nicotinic antagonist pretreatments in mice. Ferulic acid at the doses of 80 mg/kg (p.o.) produced an antinociception in hot-plate tests and at the doses of 40 and 80 mg/kg in tail-immersion test. Yohimbine, naloxone, atropine and mecamylamine, but not ketanserin, reversed the antinociceptive effect of ferulic acid in hot-plate test while yohimbine, naloxone, atropine and mecamylamine, but not ketanserin, reversed the antinociception in tail-immersion test. These results indicated that ferulic acid possesses central antinociception through mechanisms that involve an interaction with supraspinal/spinal noradrenergic, opioidergic and spinal cholinergic systems, except serotonergic system. In particular, ferulic acid acts as μ-opioidergic agonists. [1, 2] . Here, our aim was to investigate the effects of sex hormones on brain white matter microstructure using the cross-sex hormone treatment of patients with gender dysphoria as a model. Methods: 24 Female-to-Male (FtM, 27.24 ± 2.4y) and 12 Maleto-Female (MtF, 26.17 ± 5.6y) transsexuals wanting sex reassignment were included. They were measured before, 4 weeks after, and 4 months after treatment start using diffusion tensor imaging on a 3T scanner. FtM received 1000mg testosterone undecanoate every 12 weeks. MtF received 50mg cyproterone acetate daily and additionally estradiol 0.75-1.5mg transdermally. DTI acquisition was performed with an isotropic resolution of 1.64mm 3 acquiring diffusion-weighted images in 30 directions with a b-value of 800s/mm 2 . Calculation of fractional anisotropy (FA), mean diffusivity (MD), axial and radial diffusivity (AD, RD) maps was done in FSL. Tract-based spatial statistics were used for spatial normalization. Statistics included repeated measures ANOVA and post-hoc pairwise comparisons at p<0.05 FWE corrected using threshold-free cluster enhancement. Results: 4 months but not 4 weeks of testosterone treatment in FtM led to significant increases in FA in a variety of tracts including fornix, corticospinal tract and superior longitudinal fasciculus, among others. Conversely, MD decreased in these tracts. These changes were based on reductions in RD and to a lesser extent AD for the investigated fibers. No significant changes were found for MtF at the two time points. Conclusions: Our results concur with a previous study [3] and match well with our recent finding of a sex difference in MD, showing higher MD values in females than in males in most white matter tracts [4] . The absence of changes in MtF may be attributed to the small sample size. These data highlight the strong impact of testosterone on white matter morphology even after puberty.
